Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; The detailed pharmacokinetics of budesonide, formoterol, and terbutaline

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 22, Issue 2, 2009, Pages 169-180

  Ewing, Per ^a   Eirefelt, Stefan J ^b   Andersson, Paul ^b   Blomgren, Anders ^b   Ryrfeldt, Åke ^a   Gerde, Per ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c DustGun Technologies AB   (Sweden)

Author keywords

dry powder aerosol; particle deposition; pharmacokinetics; pulmonary absorption

Indexed keywords

EID: 84881395618     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Service RF: Drug delivery takes a deep breath. Science. 1997;277:1199-1200.
2. Patton JS, and Byron PR: Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov. 2007;6:67-74.
3. Patton JS, Bukar J, and Nagarjan S: Inhaled insulin. Adv Drug Deliv Rev. 1999;35:235-247.
4. Miller-Larsson A, and Selroos O: Advances in asthma and COPD treatment: combination therapy with inhaled corticosteroids and long-acting beta2-agonists. Curr Pharm Des. 2006;12:3261-3279.
5. Thorsson L, Edsbacker S, Kallen A, and Lofdahl CG: Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br J Clin Pharmacol. 2001;52:529-538.
6. Ewing P, Blomgren B, Ryrfeldt A, and Gerde P: Increasing exposure levels cause an abrupt change in the absorption and metabolism of acutely inhaled benzo(a)pyrene in the isolated, ventilated, and perfused lung of the rat. Toxicol Sci. 2006;91:332-340.
7. Gerde P, Muggenburg BA, Lundborg M, and Dahl AR: The rapid alveolar absorption of diesel-soot adsorbed benzo(a)pyrene-bioavailability, metabolism, and dosimetry of an inhaled carcinogen. Carcinogenesis. 2001;22:741-749.
8. Schanker LS, and Hemberger JA: Relation between molecular weight and pulmonary absorption rate of lipid-insoluble compounds in neonatal and adult rats. Biochem Pharmacol. 1983;32:2599-2601.
9. Camner P, Lundborg M, Lastbom L, Gerde P, Gross N, and Jarstrand C: Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. J Appl Physiol. 2002;92:2608-2616.
10. Derks MG, van den Berg BT, van der Zee JS, Braat MC, and van Boxtel CJ: Biphasic effect-time courses in man after formoterol inhalation: eosinopenic and hypokalemic effects and inhibition of allergic skin reactions. J Pharmacol Exp Ther. 1997;283:824-832.
11. Coraux C, Kileztky C, Polette M, Hinnrasky J, Zahm JM, Devillier P, De Bentzmann S, and Puchelle F: Airway epithelial integrity is protected by a long-acting beta2-adrenergic receptor agonist. Am J Respir Cell Mol Biol. 2004;30:605-612.
12. Tiruppathi C, Naqvi T, Wu Y, Vogel SM, Minshall RD, and Malik AB: Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells. Proc Natl Acad Sci USA 2004;101:7699-7704.
13. Sakagami M, Byron PR, and Rypacek F: Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors. J Pharm Sci. 2002;91:1958-1968.
14. Brchot J-M, Hurbain I, Fajac A, Daty N, and Bernaudin J-F: Different pattern of MRP localization in ciliated and basal cells from human bronchial epithelium. J Histochem Cytochem. 1998;46:513-517.
15. Horvath G, Schmid N, Fragoso MA, Schmid A, Conner GE, Salathe M, and Wanner A: Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am J Respir Cell Mol Biol. 2007;36:53-60.
16. Jendbro M, Johansson CJ, Strandberg P, Falk-Nilsson H, and Edsbacker S: Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat. Drug Metab Dispos. 2001;29:769-776.
17. Suhara T, Sudo Y, Yoshida K, Okubo Y, Fukuda H, Obata T, Yoshikawa K, Suzuki K, and Sasaki Y: Lung as reservoir for antidepressants in pharmacokinetic drug interactions. Lancet. 1998;351:332-335.
18. Kuss H, Hoefgen N, Johanssen S, Kronbach T, and Rundfeldt C: In vivo efficacy in airway disease models of N-(3,5-dichloropyrid-4-yl)-[1-(4- fluorobenzyl)- 5-hydroxy-indole-3-yl]-glyo xylic acid amide (AWD 12-281), a selective phosphodiesterase 4 inhibitor for inhaled administration. J Pharmacol Exp Ther. 2003; 307:373-385.
19. Tronde A, Norden B, Jeppsson AB, Brunmark P, Nilsson E, Lennerns H, and Bengtsson UH: Drug absorption from the isolated perfused rat lung-correlations with drug physicochemical properties and epithelial permeability. J Drug Target. 2003;11:61-74.
20. Ryrfeldt A, Andersson P, Edsbacker S, Tonnesson M, Davies D, and Pauwels R: Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis Suppl. 1982;122:86-95.
21. Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, and Schlesinger RR: Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci. 2000;55:24-35.
22. Byron PR, Roberts NS, and Clark AR: An isolated perfused rat lung preparation for the study of aerosolized drug deposition and absorption. J Pharm Sci. 1986; 75:168-171.
23. Gerde P, Ewing P, Lastbom L, Ryrfeldt A, Waher J, and Liden G: A novel method to aerosolize powder for short inhalation exposures at high concentrations: isolated rat lungs exposed to respirable diesel soot. Inhal Toxicol. 2004;16:45-52.
24. Schmekel B, Borgstrom L, and Wollmer P: Difference in pulmonary absorption of inhaled terbutaline in healthy smokers and non-smokers. Thorax. 1991;46: 225-228.
25. Rosenborg J, Bengtsson T, Larsson P, Blomgren A, Persson G, and Lotvall J: Relative systemic dose potency and tolerability of inhaled formoterol and salbutamol in healthy subjects and asthmatics. Eur J Clin Pharmacol. 2000;56:363-370.
26. Sabty-Daily RA, Hinds WC, and Froines JR: Size distribution of chromate paint aerosol generated in a bench-scale spray booth. Ann Occup Hyg. 2005;49: 33-45.
27. Hofmann W, Asgharian B, Bergmann R, Anjilvel S, and Miller FJ: The effect of heterogeneity of lung structure on particle deposition in the rat lung. Toxicol Sci. 2000;53:430-437.
28. Dahlin KL, Lastbom L, Blomgren B, and Ryrfeldt A: Acute lung failure induced by tricyclic antidepressants. Toxicol Appl Pharmacol. 1997;146:309-316.
29. Sakagami M: In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev. 2006;58:1030-1060.
30. Anderson GP, Linden A, and Rabe KF: Why are longacting beta-adrenoceptor agonists long-acting? Eur Respir J. 1994;7:569-578.
31. Bengtsson B, and Fagerstrom PO: Extrapulmonary effects of terbutaline during prolonged administration. Clin Pharmacol Ther. 1982;31:726-732.
32. Raabe OG, Yeh H-C, Newton GJ, Phalen RF, and Velasquez DJ: Deposition of inhaled monodisperse aerosols in small rodents. In: WH Walton (ed.). Inhaled Particles IV. Pergamon Press, Oxford; pp. 3-21, 1977.
33. Anjilvel S, and Asgharian B: A multiple-path model of particle deposition in the rat lung. Fundam Appl Toxicol. 1995;28:41-50.